⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

November 1, 2017Journal for ImmunoTherapy of CancerOpen Access

32nd Annual Meeting and Pre-Conference Programs of the Society for Immunotherapy of Cancer (SITC 2017): Part Two

View Full Paper

Ask AI

Bookmark

Share

Abstract

### Clinical Trials (In Progress) #### P218 KEYNOTE-585: randomized, phase 3 study of chemotherapy + pembrolizumab vs chemotherapy + placebo as neoadjuvant/adjuvant treatment for patients with gastric or gastroesophageal junction (G/GEJ) cancer ##### Yung-Jue Bang1, Eric Van Cutsem2, Charles

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

A 2017 study studied this question.

synapsesocial.com/papers/6a73e1f643194bd21bf15ed2 https://doi.org/10.1186/s40425-017-0288-4

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 related papers. Consider them for comparative context:

1Hormone therapy potentiates chemoimmunotherapy by inducing SUMOylation-mediated immunogenic cell deathJournal for ImmunoTherapy of Cancer · 2026
2Propionate promotes CD8 + T-cell infiltration and enhances immunotherapy efficacy in colorectal cancerJournal for ImmunoTherapy of Cancer · 2026
3PTPN22 as a novel therapeutic target: a key intracellular checkpoint for NK cell therapyJournal for ImmunoTherapy of Cancer · 2026
4Toripalimab consolidation after chemoradiotherapy in limited-stage small cell lung cancer: a phase II, randomized controlled study (GASTO-1052A)Journal for ImmunoTherapy of Cancer · 2026
5Poliosis predicts durable response to immune-checkpoint blockade in metastatic melanoma: a multicenter cohort studyJournal for ImmunoTherapy of Cancer · 2026

Stereotactic body radiation therapy enriches mediators of humoral immune activity in metastatic renal cell carcinomaJournal for ImmunoTherapy of Cancer · 2026
Affinity-optimized bispecific CAR-T cells targeting HLA-G and CD70 for the treatment of clear cell renal cell carcinomaJournal for ImmunoTherapy of Cancer · 2026
PARP1-selective inhibitor DSB1559 demonstrates superior efficacy and antitumor immunity in triple-negative breast cancerJournal for ImmunoTherapy of Cancer · 2026
Ectopic rabphilin-3A expression in lung adenocarcinoma associated with paraneoplastic arginine vasopressin deficiency during anti-PD-L1 therapy: a case reportJournal for ImmunoTherapy of Cancer · 2026
IL7R mRNA therapy enhances antitumor T cell immunity and suppresses tumor growth in preclinical tumor modelsJournal for ImmunoTherapy of Cancer · 2026

More from Journal for ImmunoTherapy of Cancer